News Listing

News Listing

An enzyme that enables the pathway to diabetes

An enzyme that enables the pathway to diabetes

MEDIA RELEASE: Jun 29, 2015 06:00 AM
Garvan scientists believe they have identified an enzyme that undermines a delicately balanced whole-body system that keeps blood sugar levels stable and low in healthy people. The collapse of this system in the pancreas, the liver and muscle leads to diabetes.

More…

Garvan Institute announces recipient of the Connie Johnson Fellowship in Breast Cancer Research

Garvan Institute announces recipient of the Connie Johnson Fellowship in Breast Cancer Research

MEDIA RELEASE: May 27, 2015 09:50 AM
The recipient of the inaugural Connie Johnson Fellowship in Breast Cancer at the Garvan Institute of Medical Research will be announced in Parliament House today.

More…

2015 Heliflite Young Explorer and CHAMP Young Pioneer Award winners announced

2015 Heliflite Young Explorer and CHAMP Young Pioneer Award winners announced

May 25, 2015 01:03 PM
The recipients of the Heliflite Young Explorer and CHAMP Private Equity Young Pioneer Awards were announced at Garvan’s Annual General Meeting, celebrating the successes of 2014.

More…

Professor Susan Clark elected Fellow of the Australian Academy of Science

Professor Susan Clark elected Fellow of the Australian Academy of Science

MEDIA RELEASE: May 25, 2015 12:01 AM
Professor Susan Clark, Head of the Genomics and Epigenetics Division at Garvan, has been elected Fellow of the Australian Academy of Science in recognition of her outstanding contributions to science and scientific research.

More…

Frontline immune cells can travel for help

Frontline immune cells can travel for help

MEDIA RELEASE: May 14, 2015 07:00 PM
A new study shows that 'neutrophils', cells which form the bulk of our fast-acting ‘innate’ immune system, behave differently, depending on whether an injury is infected or not.

More…

A trigger that likely unleashes autoimmune disease

A trigger that likely unleashes autoimmune disease

MEDIA RELEASE: May 13, 2015 05:30 AM
Australian researchers believe they have discovered a group of cells that trigger autoimmune disease, as well as the molecular ‘trigger guard’ that normally holds them in check. These previously undetected cells are renegade versions of the cells that make the ‘high affinity’ antibodies required for long-term immunity.

More…

The Napoleonic proportions of insulin’s journey in a fat cell

The Napoleonic proportions of insulin’s journey in a fat cell

May 08, 2015 02:00 AM
Garvan and CSIRO biodata visualisation expert Dr Sean O’Donoghue was inspired by famous French cartographer, Charles Minard, in representing what happens when insulin strikes the surface of a fat cell.

More…

Garvan scientist selected to set  ovarian cancer prevention research priorities in US

Garvan scientist selected to set ovarian cancer prevention research priorities in US

MEDIA RELEASE: May 07, 2015 12:29 PM
New position will see Garvan’s Dr Goli Samimi setting direction of ovarian cancer prevention research and funding in US

More…

Insight into how we protect ourselves from certain bacteria and fungi

Insight into how we protect ourselves from certain bacteria and fungi

MEDIA RELEASE: May 04, 2015 11:00 PM
Australian scientists have shown that a specific gene determines the development and function of important cells that shield us against a variety of fungal and bacterial infections.

More…

Morning Tea Event Held for Garvan Supporters

Morning Tea Event Held for Garvan Supporters

Apr 23, 2015 01:50 PM
For every dollar Garvan receives from competitive Government grants we need to raise 70c to carry out our research, and we are very privileged to be the recipient of generous support in helping us achieve this. Yesterday we thanked some of our valued supporters with a morning tea event in our galleria.

More…

Throwing light on how to conduct a personalised pancreas cancer clinical trial

Throwing light on how to conduct a personalised pancreas cancer clinical trial

MEDIA RELEASE: Apr 20, 2015 10:00 PM
Australian leaders of an ongoing pancreatic cancer clinical trial known as the Individualised Molecular Pancreatic Cancer Therapy or ‘IMPaCT’ trial, have been learning ways to bring about a new paradigm of personalised cancer care for pancreatic cancer and other aggressive cancer types.

More…

Garvan welcomes Professor Mark Febbraio as Head of Diabetes and Metabolism

Garvan welcomes Professor Mark Febbraio as Head of Diabetes and Metabolism

Apr 08, 2015 12:00 AM
Garvan is very pleased to announce that Professor Mark Febbraio has joined us as Head of the Diabetes and Metabolism Division

More…

Professors Mattick and Eisman inducted into Australian Academy of Health and Medical Sciences

Professors Mattick and Eisman inducted into Australian Academy of Health and Medical Sciences

Apr 07, 2015 04:00 AM
Executive Director of Garvan, Professor John Mattick AO FAA FRCPA, and Endocrinologist Professor John Eisman AO, were recently inducted as Fellows of the newly-created Academy of Health and Medical Sciences.

More…

Memory immune cells that screen intruders as they enter lymph nodes

Memory immune cells that screen intruders as they enter lymph nodes

MEDIA RELEASE: Apr 01, 2015 03:00 AM
Garvan scientists have discovered a new population of ‘memory’ immune cells, throwing light on what the body does when it sees a microbe for the second time. This insight, and others like it, will enable the development of more targeted and effective vaccines.

More…

How bones reflect genetic variation among populations

How bones reflect genetic variation among populations

MEDIA RELEASE: Mar 30, 2015 01:00 AM
Genes that help build strong bones in Europeans or Australians may have a very different effect in people from Southeast Asia.

More…

The switch that might tame the most aggressive of breast cancers

The switch that might tame the most aggressive of breast cancers

MEDIA RELEASE: Mar 27, 2015 09:00 PM
Garvan researchers have found that so-called ‘triple-negative breast cancers’ are two distinct diseases that likely originate from different cell types. They have also found a gene that drives the aggressive disease, and hope to find a way to ‘switch it off’.

More…

The Michael J. Fox Foundation supports promising Parkinson’s project

The Michael J. Fox Foundation supports promising Parkinson’s project

MEDIA RELEASE: Mar 23, 2015 12:05 AM
Garvan scientists receive support from The Michael J. Fox Foundation for Parkinson’s Research to speed progress in developing a novel therapy for Parkinson’s disease.

More…

New gene sequencing technology like a high-powered microscope

New gene sequencing technology like a high-powered microscope

MEDIA RELEASE: Mar 10, 2015 03:00 AM
A new gene sequencing technology known as ‘Capture Sequencing’ (CaptureSeq) allows us to explore the human genome at a much higher resolution than ever before, with revolutionary implications for research and cancer diagnosis.

More…

How the landscape of the pancreatic cancer genome is coming into view

How the landscape of the pancreatic cancer genome is coming into view

MEDIA RELEASE: Feb 26, 2015 05:00 AM
Scientists from Australia and the UK have done the most in-depth analysis yet of 100 pancreatic cancer genomes and highlighted 4 subtypes that may help guide future patient treatment. The study is published in Nature today.

More…